financetom
Business
financetom
/
Business
/
Worthington Enterprises Delivers Q2 Earnings Beat: Growth In Building Products Drives Momentum
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Worthington Enterprises Delivers Q2 Earnings Beat: Growth In Building Products Drives Momentum
Dec 18, 2024 5:09 AM

Worthington Enterprises, Inc ( WOR ). shares traded higher premarket on Wednesday after the company reported second-quarter financial results.

On Tuesday, the company reported a net sales decline of 8% year over year to $274.0 million, beating the consensus of $273.77 million. The decline was attributed to the deconsolidation of the former Sustainable Energy Solutions segment.

Adjusted EBITDA increased 2% to $56.2 million. Adjusted EPS of $0.60 exceeded the consensus of $0.52.

By segment, Consumer Products’ net sales fell 2.2% to $116.7 million in the quarter, with adjusted EBITDA coming in at $15.5 million, up $2.8 million over the prior year quarter. Meanwhile, Building Products generated net sales of $157.3 million, up 4.0% year-over-year.

Total debt at quarter end consisted entirely of long-term debt and was relatively unchanged from May 31, 2024, at $295.7 million and cash stood at $193.8 million.

The Board of Directors declared a quarterly dividend of $0.17 per common share, payable on March 28, 2025, to shareholders of record as of March 14, 2025.

In the quarter, the company repurchased 200,000 common shares for $8.1 million, with 5.715 million shares remaining under the share repurchase authorization.

Worthington Enterprises ( WOR ) President and CEO Joe Hayek said, “Consumer Products’ earnings growth was driven by increased volumes and improved gross margins. Building Products generated higher earnings driven by the inclusion of Ragasco and stronger contributions from WAVE.”

“We have improved our value propositions in multiple product lines over the last year, and we are very well positioned as growth returns to our end markets. Led by our people-first, performance-based culture, leveraging a solid balance sheet and a commitment to transformation, innovation and M&A, we are confident in our ability to optimize our business, drive sustainable growth and deliver long-term value to our shareholders.”

Price Action: WOR shares are up 12.6% at $43.00 premarket at the last check Wednesday.

Read Next:

US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Choice Hotels International Insider Sold Shares Worth $650,328, According to a Recent SEC Filing
Choice Hotels International Insider Sold Shares Worth $650,328, According to a Recent SEC Filing
Jul 9, 2025
05:08 PM EDT, 07/09/2025 (MT Newswires) -- Dominic Dragisich, Executive Vice President, Operations and Chief Global Brand Officer, on July 08, 2025, sold 4,900 shares in Choice Hotels International ( CHH ) for $650,328. Following the Form 4 filing with the SEC, Dragisich has control over a total of 70,881 common shares of the company, with 70,881 shares held directly....
Ultragenyx, Mereo Advance Phase 3 Study of Genetic Bone Disorder Toward Final Analysis
Ultragenyx, Mereo Advance Phase 3 Study of Genetic Bone Disorder Toward Final Analysis
Jul 9, 2025
05:11 PM EDT, 07/09/2025 (MT Newswires) -- Ultragenyx (RARE) and Mereo BioPharma ( MREO ) said Wednesday that the placebo-controlled portion of a pivotal phase 3 study of UX143 (setrusumab) for osteogenesis imperfecta is advancing to final analysis as planned, with data expected by year-end. The study's independent data monitoring committee affirmed that the candidate maintains an acceptable safety profile,...
Vermilion Energy Edges Up After Hours as It Renews Its Normal-Course Issuer Bid
Vermilion Energy Edges Up After Hours as It Renews Its Normal-Course Issuer Bid
Jul 9, 2025
05:08 PM EDT, 07/09/2025 (MT Newswires) -- Vermilion Energy ( VET ) edged up in after-hours New York trading after the company on Wednesday said it received exchange approvals to renew its normal-course issuer bid for 12 months. The oil and gas producer it can buy back and cancel up to 15.26-million shares in the year beginning July 12, 10%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved